Artillery Startup Raises $85M to Expand Licensing

Tiberius Aerospace's funding will support its partner network for precision munitions still in contract and development stages.

Updated on Nov. 17, 2026 in Startups

Bold flat-color editorial illustration of a row of artillery shell forms in a steel-grey bay, rendered in deep red, cream, and brass.
Tiberius Aerospace raised $85 million in a Series A round led by Lakestar and Rochefort Asset Management, valuing the company above $1 billion. AI Illustration. Upload story photo >

Tiberius Aerospace, a company founded in 2022 that develops precision-guided artillery ammunition and AI-powered defence manufacturing, raised an $85 million Series A round led by Zurich-based Lakestar and US firm Rochefort Asset Management. The company is now valued at more than $1 billion. The funding is a financing event for a company whose products are in the contract and development stage rather than broadly fielded.

Why it matters

The round signals investor appetite for defence technology built around licensing rather than direct production, with allied nations building systems locally. The company's model, in which it keeps the intellectual property and uses private capital for development, tests whether venture financing can carry munitions development that has traditionally depended on government budgets.

The Sceptre munition is a long-range, precision-guided 155mm artillery round, and the company's stated model is to license systems to allied nations that build them locally. The source provides no performance benchmarks, range figures, or accuracy metrics for Sceptre, so its technical capabilities beyond its caliber and precision-guided classification remain unverified.

The players

Tiberius Aerospace

A defence manufacturer founded in 2022 that licenses precision-guided 155mm artillery systems, with offices in the US and UK.

Lakestar

A Zurich-based investment firm that led the Series A round in Tiberius Aerospace.

Rochefort Asset Management

A US investment firm that co-led the Series A round in Tiberius Aerospace.

The details

Tiberius Aerospace develops precision-guided artillery ammunition, and its Sceptre product is a long-range munition designed for the 155mm artillery caliber used by many NATO-standard guns. The company licenses its systems to allied nations, which build them locally and bear the cost of plant and tooling, while Tiberius retains the intellectual property. Private capital funds the development, testing and validation work, so the company does not depend on upfront government funding for each stage.

Timeline

  1. Tiberius Aerospace was founded in 2022.

  2. The UK Ministry of Defence contract to develop and test Sceptre was secured last year.

  3. A $500 million Sceptre manufacture, licensing and distribution contract was announced last month.

  4. The $85 million Series A round was announced on November 17, 2026.

The Tech Race

Tiberius Aerospace's licensing structure, in which allied nations build munitions locally while the company keeps the intellectual property, positions it as a venture-backed alternative to traditional prime-contractor production. The source does not name competing precision-munition programs, so the company's position relative to other artillery developers cannot be assessed from this report.

The round affects defence procurement and allied governments that may license Sceptre, not general consumers. Availability and timelines for Sceptre deliveries under the $500 million contract were not stated in the source.

The takeaway

The licensing model, in which allied nations build munitions locally while Tiberius keeps the intellectual property, is the trajectory to watch. Track whether the $500 million Sceptre contract moves to production volumes in the coming year.

Further reading

For more on how young companies raise and scale capital, see our Startups coverage.